A103: An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues

American Journal of Surgical Pathology

Volumn 22, Issue 5, 1998, Pages 595-602

  Jungbluth, Achim A ^a   Busam, Klaus J ^a   Gerald, William L ^a   Stockert, Elisabeth ^a   Coplan, Keren A ^a   Iversen, Kristin ^a   MacGregor, Duncan P ^b   Old, Lloyd J ^a,c   Chen, Yao Tseng ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

HMB45; Hybridoma; MART 1; Melan A; Melanoma; Metastasis

Indexed keywords

DIFFERENTIATION ANTIGEN; FORMALDEHYDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A103; MONOCLONAL ANTIBODY HMB 45; PARAFFIN; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ANGIOMYOLIPOMA; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMBEDDING; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; SPINDLE CELL; THECA CELL; TUMOR DIFFERENTIATION;

ANGIOMYOLIPOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; NEOPLASM PROTEINS; NEVUS; PARAFFIN EMBEDDING; SKIN NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0031922272     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199805000-00011     Document Type: Article

References (35)

1. Achilles E, Schröder S. Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistological diagnosis of occult neoplasms. Pathologe 1994;15:235-41.
2. Adema GJ, de Boer AJ, van't Hullenaar R, et al. Melanocyte lineage specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 1993;143:1579-85.
3. Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Wilson Jones E. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14-22.
4. Bacchi CE, Bonetti F, Pea M, Martignoni G, Gown AM. HMB-45. A review. Appl Immunohistochem 1996;4:73-85.
5. Bakker ABH, Schreurs MWJ, de Boer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor infiltrating lymphocytes. J Exp Med 1994;179:1005-9.
6. Boël P. Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-75.
7. Brichard V, van Pel A, Wölfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-95.
8. Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998;22:57-63.
9. Chen YT, Stocken E, Tsang S, Coplan KA, Old LJ. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development. Proc Natl Acad Sci USA 1995;92:8125-9.
10. Chen YT, Stocken E, Jungbluth A, et al. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996;93:5915-9.
11. Chintamaneni C, Halaban R, Kobayashi Y, Witkop CJ, Kwon BS. A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism. Proc Natl Acad Sci USA 1991;88:5272-6.
12. Coulie PG, Brichard V, van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
13. Cox AL, Skipper, Chen Y, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994;264:716-9.
14. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994;40:360-9.
15. Fetsch PA, Cormier J, Hijazi YM. Immoncytochemical detection of MART-1 in fresh and paraffin embedded malignant melanomas. J Immunother 1996;20:60-4.
16. Gaugler B, van den Eynde B. van der Bruggen P. et al. Human gene Mage-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
17. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1988;123:195-203.
18. Jäger E, Bernhard H. Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996;66:162-7.
19. + cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int J Cancer 1996;66:470-6.
20. Kaiserling E, Kröber S. Xiao JC, Schaumburg-Lever G. Angiomyolipoma of the kidney. Immunoreactivity with HMB-45. Lightand electron-microscopic findings. Histopathology 1994;25:41-8.
21. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9.
22. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
23. Kwon BS. Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J Invest Dermatol 1993;100 (suppl):134S-40S.
24. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle cell malignant melanoma. An immunohistochemical study. Am J Surg Path 1996;20:1489-500.
25. Marincola FM. Hijazi YM, Fetsch P, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp-100 in metastatic melanoma cell lines and in situ lesions. J Immunother 1996;19:192-205.
26. Mattes MJ, Thomson TM, Old LJ, Lloyd K. A pigmentationassociated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer 1983;32:717-21.
27. Pea M, Bonetti F, Zamboni G, et al. Melanocyte-marker HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991;23:185-8.
28. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994;54:3124-6.
29. Sarantou T, Chi DDJ. Garrison DA, et al. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997;57:1371-6.
30. Smoller BR, Hsu A, Krueger J. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 1991;81:315-22.
31. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 1997;45: 327-43.
32. Skelton HG, Smith KJ, Barren TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 1991;13:543-50.
33. Van den Eynde B, Peeter O, de Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on human melanoma. J Exp Med 1995;182:689-98.
34. Van der Bruggen P, Traversari C, Chomez C, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
35. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenber SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31 -restricted tumor-infiltrating lymphocytes. J Exp Med 1995;181:799-804.